Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$156.98
+1.9%
$151.30
$101.00
$159.42
$10.29B0.84610,383 shs1.99 million shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$105.20
-1.4%
$103.02
$92.77
$127.99
$10.60B0.721.04 million shs1.07 million shs
NEMD
iNeedMD
$52.69
+0.5%
$52.47
$49.83
$55.25
$2.53B-1.2910,941 shs6,094 shs
Revvity Inc. stock logo
RVTY
Revvity
$92.32
+6.7%
$90.23
$81.22
$118.30
$9.67B1.051.10 million shs2.08 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
0.00%+1.06%+4.13%+12.82%+7.73%
Encompass Health Corporation stock logo
EHC
Encompass Health
0.00%+6.33%+10.53%+14.00%-7.92%
NEMD
iNeedMD
0.00%+0.13%+2.25%-0.23%+26,364,900.00%
Revvity Inc. stock logo
RVTY
Revvity
0.00%-0.23%-2.65%-13.98%-7.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$156.98
+1.9%
$151.30
$101.00
$159.42
$10.29B0.84610,383 shs1.99 million shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$105.20
-1.4%
$103.02
$92.77
$127.99
$10.60B0.721.04 million shs1.07 million shs
NEMD
iNeedMD
$52.69
+0.5%
$52.47
$49.83
$55.25
$2.53B-1.2910,941 shs6,094 shs
Revvity Inc. stock logo
RVTY
Revvity
$92.32
+6.7%
$90.23
$81.22
$118.30
$9.67B1.051.10 million shs2.08 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
0.00%+1.06%+4.13%+12.82%+7.73%
Encompass Health Corporation stock logo
EHC
Encompass Health
0.00%+6.33%+10.53%+14.00%-7.92%
NEMD
iNeedMD
0.00%+0.13%+2.25%-0.23%+26,364,900.00%
Revvity Inc. stock logo
RVTY
Revvity
0.00%-0.23%-2.65%-13.98%-7.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$155.80-0.75% Downside
Encompass Health Corporation stock logo
EHC
Encompass Health
3.11
Buy$144.1737.05% Upside
NEMD
iNeedMD
0.00
N/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
2.15
Hold$109.3618.46% Upside

Current Analyst Ratings Breakdown

Latest NEMD, EHC, DVA, and RVTY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
Lower Price TargetOverweight$153.00 ➝ $140.00
5/4/2026
Revvity Inc. stock logo
RVTY
Revvity
Lower Price TargetOutperform$129.00 ➝ $125.00
4/14/2026
Revvity Inc. stock logo
RVTY
Revvity
Reiterated RatingOverweightEqual Weight$118.00 ➝ $95.00
4/14/2026
Revvity Inc. stock logo
RVTY
Revvity
DowngradeOverweightEqual Weight$118.00 ➝ $95.00
4/14/2026
Revvity Inc. stock logo
RVTY
Revvity
Lower Price TargetNeutral$110.00 ➝ $95.00
4/6/2026
DaVita Inc. stock logo
DVA
DaVita
DowngradeStrong-BuyHold
3/31/2026
Revvity Inc. stock logo
RVTY
Revvity
Lower Price TargetNeutral$105.00 ➝ $96.00
3/18/2026
Revvity Inc. stock logo
RVTY
Revvity
DowngradeHold (C-)Sell (D+)
2/26/2026
Revvity Inc. stock logo
RVTY
Revvity
UpgradeSell (D+)Hold (C-)
2/6/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
Boost Price TargetOverweight$150.00 ➝ $153.00
2/5/2026
DaVita Inc. stock logo
DVA
DaVita
Set Price Target$158.00
(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DaVita Inc. stock logo
DVA
DaVita
$13.64B0.77$22.14 per share7.09($5.29) per share-29.68
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.94B1.76$8.77 per share11.99$33.28 per share3.16
NEMD
iNeedMD
N/AN/AN/AN/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$2.86B3.61$9.41 per share9.81$63.95 per share1.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DaVita Inc. stock logo
DVA
DaVita
$746.80M$9.9115.849.290.545.47%-413.18%4.70%5/5/2026 (Estimated)
Encompass Health Corporation stock logo
EHC
Encompass Health
$566.20M$5.9917.5616.391.9910.04%18.28%8.27%N/A
NEMD
iNeedMD
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$241.20M$2.0844.3815.411.848.45%7.92%4.81%5/5/2026 (Confirmed)

Latest NEMD, EHC, DVA, and RVTY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
DaVita Inc. stock logo
DVA
DaVita
$2.33$2.87+$0.54$2.87$3.36 billion$3.42 billion
5/5/2026Q1 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.02$1.06+$0.04$0.36$704.20 million$711.12 million
4/30/2026Q1 2026
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.51$1.60+$0.09$1.93$1.57 billion$1.59 billion
2/5/2026Q4 2025
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.29$1.46+$0.17$1.43$1.54 billion$3.09 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.760.72%-8.97%12.69%2 Years
NEMD
iNeedMD
$2.244.25%N/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.30%N/A13.46%N/A

Latest NEMD, EHC, DVA, and RVTY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2026
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.32%7/17/20267/17/20268/7/2026
2/19/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.190.78%4/1/20264/1/20264/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DaVita Inc. stock logo
DVA
DaVita
N/A
1.29
1.24
Encompass Health Corporation stock logo
EHC
Encompass Health
0.76
1.17
1.08
NEMD
iNeedMD
N/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
0.36
1.68
1.40

Institutional Ownership

CompanyInstitutional Ownership
DaVita Inc. stock logo
DVA
DaVita
90.12%
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
NEMD
iNeedMD
N/A
Revvity Inc. stock logo
RVTY
Revvity
86.65%

Insider Ownership

CompanyInsider Ownership
DaVita Inc. stock logo
DVA
DaVita
1.50%
Encompass Health Corporation stock logo
EHC
Encompass Health
1.80%
NEMD
iNeedMD
N/A
Revvity Inc. stock logo
RVTY
Revvity
0.85%
CompanyEmployeesShares OutstandingFree FloatOptionable
DaVita Inc. stock logo
DVA
DaVita
78,00066.80 million65.80 millionOptionable
Encompass Health Corporation stock logo
EHC
Encompass Health
42,00099.42 million97.63 millionOptionable
NEMD
iNeedMD
348.01 millionN/ANot Optionable
Revvity Inc. stock logo
RVTY
Revvity
11,000111.80 million110.85 millionOptionable

Recent News About These Companies

Revvity (NYSE:RVTY) Surprises With Q1 CY2026 Sales
Revvity: Q1 Earnings Snapshot
Revvity (RVTY) Q1 2026 Earnings Transcript
Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript
Revvity Q1 Earnings Call Highlights
Revvity (NYSE:RVTY) Updates FY 2026 Earnings Guidance
Revvity earnings: What to look for from RVTY
Revvity (RVTY) Expected to Announce Earnings on Tuesday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DaVita stock logo

DaVita NYSE:DVA

$156.98 +2.90 (+1.88%)
Closing price 03:59 PM Eastern
Extended Trading
$165.69 +8.71 (+5.55%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Encompass Health stock logo

Encompass Health NYSE:EHC

$105.20 -1.44 (-1.35%)
Closing price 03:59 PM Eastern
Extended Trading
$104.28 -0.92 (-0.88%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

iNeedMD OTCMKTS:NEMD

$52.69 +0.27 (+0.52%)
As of 04:10 PM Eastern

iNeedMD Holdings, Inc. is a medical device company, which engages in the development and provision of disposable devices used in the diagnosis, prevention, and monitoring of cardiovascular diseases. It offers EKG Glove, a medical device that used in diagnostic electrocardiograms. The company was founded by Govindan Gopinathan on February 1, 2012 and is headquartered in New York, NY.

Revvity stock logo

Revvity NYSE:RVTY

$92.32 +5.81 (+6.71%)
Closing price 03:59 PM Eastern
Extended Trading
$97.76 +5.44 (+5.89%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.